4//SEC Filing
Lemercier Jean-Luc M 4
Accession 0001225208-24-005702
CIK 0001099800other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 7:18 PM ET
Size
10.0 KB
Accession
0001225208-24-005702
Insider Transaction Report
Form 4
Lemercier Jean-Luc M
CVP, EMEA, Canada, Latin Amer
Transactions
- Exercise/Conversion
Performance Rights
2024-05-04−4,157→ 0 totalFrom: 2024-05-04Exp: 2028-05-03→ Common Stock (4,157 underlying) - Tax Payment
Common Stock
2024-05-03$85.06/sh−37$3,147→ 173,811.806 total - Tax Payment
Common Stock
2024-05-06$85.25/sh−259$22,080→ 177,709.806 total - Exercise/Conversion
Common Stock
2024-05-04+4,157→ 177,968.806 total
Footnotes (1)
- [F1]On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001710625
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 7:18 PM ET
- Size
- 10.0 KB